The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics
Manage episode 435363652 series 3594399
We speak to Dimerix CEO Dr Nina Webster about why investors are thrilled with her company, as it nears the midway point for its Phase III clinical trial for the rare disease focal segmental glomerulosclerosis (FSGS).
And we talk to PYC Therapeutics CEO Dr Rohan Hockings about how his company's tech actually works to treat polycystic kidney disease.
Produced by Rachel Williamson and Charis Palmer. Music and effect credits to Ziso, Inspector J, Seth Parson and Boom Library.
Capíttulos
1. The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics (00:00:00)
2. PYC Therapeutics CEO Dr Rohan Hockings (00:02:00)
3. Dimerix CEO Dr Nina Webster (00:13:57)
13 episodios